Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Sponsor: Verastem, Inc.
Check if you qualify for this ovarian cancer clinical trial in San Francisco, CA
If you're searching for ovarian cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.